Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial

Published:2016-10-06 Issue:1 Volume:19 Page:78-86
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Josse Robert G.¹,Majumdar Sumit R.²,Zheng Yinggan³,Adler Amanda⁴,Bethel M. Angelyn⁵,Buse John B.⁶,Green Jennifer B.⁷,Kaufman Keith D.⁸,Rodbard Helena W.⁹,Tankova Tsvetalina¹⁰,Westerhout Cynthia M.³,Peterson Eric D.⁷,Holman Rury R.⁵,Armstrong Paul W.³,

Affiliation:

1. St. Michael's Hospital; University of Toronto; Toronto Ontario Canada

2. Department of Medicine; University of Alberta; Edmonton Alberta Canada

3. Canadian VIGOUR Centre; University of Alberta; Edmonton Alberta Canada

4. Wolfson Diabetes and Endocrine Clinic, Addenbrooke's Hospital; Cambridge University Hospitals Foundation Trust; Cambridge UK

5. Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism; University of Oxford; Oxford UK

6. University of North Carolina School of Medicine; Chapel Hill

7. Duke Clinical Research Institute; Duke University School of Medicine; Durham North Carolina

8. Merck & Co., Inc.; Kenilworth New Jersey

9. Endocrine and Metabolic Consultants; Rockville Maryland

10. Clinical Centre of Endocrinology; Medical University; Sofia Bulgaria

Funder

Merck Sharp and Dohme

Amgen

Boehringer-Ingelheim

Eli Lilly

Janssen

The Endocrine Society

BI

Sanofi and Regeneron

Novo Nordisk

Novartis

Servier

Bayer

Bristol-Myers Squib

Intarcia

University of Alberta

Endocrine Society

GlaxoSmithKline

AstraZeneca

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12786/fullpdf

Reference37 articles.

1. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis;Vestergaard;Osteoporos Int,2007

2. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture;Janghorbani;Am J Epidemiol,2007

3. Increased risk of fracture and postfracture adverse events in patients with diabetes: two nationwide population-based retrospective cohort studies;Liao;Diabetes Care,2014

4. Type 2 diabetes and the skeleton: new insights into sweet bones;Shanbhogue;Lancet Diabetes Endocrinol,2016

5. Older women with diabetes have a higher risk of falls: a prospective study;Schwartz;Diabetes Care,2002

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Qianggu concentrate: unlocking bone protection power via antioxidative SIRT1/NRF2/HO-1 pathways in type 2 diabetic osteoporosis;Frontiers in Pharmacology;2024-08-08

2. The multiple actions of dipeptidyl peptidase 4 (DPP-4) and its pharmacological inhibition on bone metabolism: a review;Diabetology & Metabolic Syndrome;2024-07-25

3. Bone Health in Patients With Type 2 Diabetes;Journal of the Endocrine Society;2024-05-23

4. Time‐dependent risk of fracture in adults with type 2 diabetes receiving anti‐diabetic drug: A one‐stage network meta‐analysis;Diabetes/Metabolism Research and Reviews;2024-02

5. Prevalence and determinants of abnormal bone metabolism among Han Chinese diabetes patients: A cross-sectional study;TROP J PHARM RES;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3